HealthQuill France
Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with hearing loss.
Health Medical Pharma

EssilorLuxottica gets regulator nod for audio glasses in US, EU for hearing loss

Franco-Italian EssilorLuxottica SA got approval from the Food and Drug Administration to market its over-the-counter audio glasses in the US for people with.

Read More
Israel has passed a law to ban the United Nations Relief and Works Agency from operating in the country after it earlier accused its employees of participation in the October 7 attacks — a move which came in for criticism from Western European leaders.
Drugs Health Medical

Israel bans UN relief agency, EU, Western European leaders slam move 

Israel has passed a law to ban the UN relief agency, UNRWA, from operating in the country after it earlier accused its employees.

Read More
Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the French company will invest 300 million euros for a 16% equity.
Drugs Health Pharma

Sanofi to invest $324m in entity with Orano Med for radioligand therapy

Sanofi and Orano Med agreed to form a new entity, valued at 1.9 billion euros ($2.06 billion), to develop radioligand medicines and the.

Read More
Servier Pharmaceuticals, the US arm of a French pharmaceutical company, got approval from the US drug regulator for a once-daily pill to treat specific forms of brain cancer.
Drugs Health Pharma

France’s Servier gets FDA green light for oral drug to treat brain cancer

Servier Pharmaceuticals, the US arm of a French pharmaceutical company, got approval from the US drug regulator for a once-daily pill to treat.

Read More
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Drugs Health Pharma

AstraZeneca acquires France’s Amolyt Pharma for $1.05 billion

British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.

Read More
The national public health agency of the US has reported a fourth person who was infected in the country with the highly pathogenic avian influenza.
Drugs Health Pharma

Bird flu detected in a fourth person in the US, health agency CDC says

The national public health agency of the US has reported a fourth person who was infected in the country with the highly pathogenic.

Read More
The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, according to a company statement.
Drugs Health Pharma

EMA approves Sanofi’s treatment for obstructive pulmonary disease

The European Medicines Agency has approved Sanofi S.A.’s Dupixent (dupilumab) therapy as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary.

Read More
The US drug regulator has granted accelerated approval for a drug to treat chronic inflammatory liver disease to Genfit, headquartered in Nord, France, and Paris-based Ipsen, according to the companies.
Drugs Health Pharma

FDA gives approval for Ispen, Genfit’s drug to treat chronic liver disease

The US drug regulator has granted accelerated approval for a drug to treat chronic inflammatory liver disease to Genfit, headquartered in Nord, France,.

Read More
Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance Minister Bruno Le Maire said, according to a publicly-funded television network, France 24.
Drugs Health Pharma

Pfizer, AstraZeneca to invest close to $1 billion in France to expand

HQ Team May 13, 2024: Pfizer and AstraZeneca will invest about $1 billion separately in France to set up and expand facilities, Finance.

Read More
About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave of the Covid-19 pandemic, according to a study.
Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

Read More